Results 201 to 210 of about 570,572 (255)

Complete Recovery After a Witnessed Ventricular Fibrillation Arrest: A Case Report. [PDF]

Cureus
Aldemir H.
europepmc   +1 more source

Arrhythmias associated with immune checkpoint inhibitor therapy—A clinical perspective

British Journal of Pharmacology, EarlyView.
Immune checkpoint inhibitors (ICIs) have transformed cancer therapy but are associated with a growing spectrum of cardiovascular immune‐related adverse events. Among these, arrhythmias represent a rare yet potentially life‐threatening complication. ICI‐induced arrhythmias encompass a wide clinical spectrum, including atrial arrhythmias, conduction ...
Dong Wang, Melanie Ricke‐Hoch, David Duncker, Johann Bauersachs, Dominik Berliner   +4 more
wiley   +1 more source

Subcutaneous Defibrillation and Coronary Sinus Pacing After Ventricular Fibrillation With Right Ventricular Metastasis. [PDF]

JACC Case Rep
Tokcan M, Abdin A, Werner C, Almasri A, Lehr A, Kulenthiran S, Schneider G, Kindermann I, Link A, Kessler T.   +9 more
europepmc   +1 more source

Heart failure medication to prevent cancer therapy–related cardiac dysfunction: A narrative review

British Journal of Pharmacology, EarlyView.
Advances in oncological therapies have improved cancer survival but also have increased the clinical incidence of cancer therapy–related cardiac dysfunction (CTRCD), a spectrum of conditions ranging from subclinical biomarker or strain abnormalities to progressive heart failure and cardiogenic shock.
Fabian Voß, Paul Goerke, Malte Kelm, Amin Polzin   +3 more
wiley   +1 more source

Dual HeartMate 3 in total artificial heart configuration for incessant ventricular fibrillation: a case report. [PDF]

Eur Heart J Case Rep
Fu HY, Then WZ, Tsao CI, Chen YS.
europepmc   +1 more source

Bruton tyrosine kinase inhibitors and cardiovascular adverse events

British Journal of Pharmacology, EarlyView.
Abstract Bruton tyrosine kinase inhibitors (BTKi) have transformed the management of chronic lymphocytic leukaemia and other B‐cell malignancies, yet their therapeutic benefit is tempered by clinically relevant cardiovascular toxicities (predominantly atrial fibrillation, hypertension, bleeding and ventricular arrhythmias).
Massimiliano Camilli, Cristina Madaudo, Emanuela Salvatorelli, Giorgio Minotti, Pierantonio Menna   +4 more
wiley   +1 more source

Idiopathic Ventricular Fibrillation: Substrates, Mechanisms and Treatment. [PDF]

Arrhythm Electrophysiol Rev
Arnaud M, Duchateau J, Hocini M.
europepmc   +1 more source

Emerging insights into amino acid metabolism in the heart: implications for cardiovascular diseases and therapeutic targeting

British Journal of Pharmacology, EarlyView.
As a metabolically versatile organ, the heart is capable of generating energy from a wide range of substrates. Although fatty acid and glucose metabolism in the heart have been extensively studied, the contribution of amino acid metabolism to cardiac physiology and disease is gaining increasing attention.
Tayyiba Azam, Hongyuan Zhang, Min Zi, Chen Chen, Junfang Wu, Andreas Papapetropoulos, Xin Wang   +6 more
wiley   +1 more source

Ventricular fibrillation dynamics reveal regional asymmetry in resilience to cardiac arrest and predict clinical outcome. [PDF]

Cardiovasc Res
Redondo-Rodríguez A, Quintanilla JG, Macías Á, Lee P, Calvo D, Couselo-Seijas M, Marina-Breysse M, Simón-Chica A, García-Escolano A, Ramos-Prada A, Alfonso-Almazán JM, Diz-Díaz J, Gil-Martínez L, Muñoz-Romero S, Galán-Arriola C, Sánchez-González J, González-Ferrer JJ, Cañadas-Godoy V, Salgado-Aranda R, Cruz-Galbán A, García-Torrent MJ, Rojo-Álvarez JL, Saiz J, Ibañez B, Pérez-Villacastín J, Pérez-Castellano N, Jalife J, Ferrero JM, Filgueiras-Rama D.   +28 more
europepmc   +1 more source

Early sodium‐glucose co‐transporter 2 inhibitor initiation is associated with improved cardiovascular outcomes in type 2 diabetes and acute coronary syndrome

Diabetic Medicine, EarlyView.
Abstract Aims Sodium‐glucose co‐transporter 2 inhibitors have demonstrated cardiovascular benefits in individuals with type 2 diabetes mellitus, but the optimal timing of initiation in those with acute coronary syndrome is not known. This study aims to assess if early therapy at discharge is superior to delayed or no therapy in reduction in major ...
Muhammad Usman Shah, Joanna Kate Ward, Alun Roebuck, Bala Srinivasan, Paul Edward Squires, Claire Elizabeth Hills, Maxime Inghels, Kelvin Lee   +7 more
wiley   +1 more source